Consumer Alert: Use of GranuFlo® and NaturaLyte® Dialysates Linked to Risk of Cardiac Arrest

GranuFlo® and NaturaLyte® are dialysates used during kidney dialysis to remove wastes from the blood of patients with acute or chronic renal failure.  The use of GranuFlo® and NaturaLyte® has been reported in some cases to lead to a blood condition called "alkalosis," which can lead to low blood pressure and even cardiac arrest [1]. 

On May 25, 2012, the United States Food and Drug Administration (FDA) released a Safety Communication instructing health care providers to be aware of fact that GranuFlo® and NaturaLyte® can deliver an excessive amount of bicarbonate into a patient's bloodstream [1]. 

On June 27, 2012, the FDA issued a Class 1 recall of GranuFlo® and NaturaLyte®.  A Class 1 recall is used when there is a reasonable probability the product will cause serious health consequences or death [2]. 

Robins, Kaplan, Miller & Ciresi L.L.P. is investigating cases involving GranuFlo® and NaturaLyte®.  If you or someone you know has suffered serious injury following hemodialysis with GranuFlo® or NaturaLyte® dialysate and you wish to consult with a lawyer, please call at 1-800-553-9910 or contact us.


The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.